IndraLab

Statements



reach
"These results demonstrated that the PI3K inhibitor LY294002 could reduce Jab1 and beta-catenin but promote BRSK1 expression; BRSK1 expression might be at least associated with the PI3K and Akt pathway[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"